|
Name |
18-des-oxycytochalasin H
|
Molecular Formula | C31H41NO4 | |
IUPAC Name* |
(16-benzyl-12-hydroxy-4,5,7,14-tetramethyl-13-methylidene-18-oxo-17-azatricyclo[9.7.0.01,15]octadeca-3,9-dien-2-yl)acetate
|
|
SMILES |
C=C1C(C)C2C(Cc3ccccc3)NC(=O)C23C(OC(C)=O)C=C(C)C(C)CC(C)CC=CC3C1O
|
|
InChI |
InChI=1S/C31H41NO4/c1-18-11-10-14-25-29(34)22(5)21(4)28-26(17-24-12-8-7-9-13-24)32-30(35)31(25,28)27(36-23(6)33)16-20(3)19(2)15-18/h7-10,12-14,16,18-19,21,25-29,34H,5,11,15,17H2,1-4,6H3,(H,32,35)/b14-10+,20-16+/t18-,19?,21+,25-,26-,27+,28-,29+,31+/m0/s1
|
|
InChIKey |
MCNZZUGTZRTMTL-VZWQHPLKSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 491.67 | ALogp: | 5.0 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 75.6 | Aromatic Rings: | 4 |
Heavy Atoms: | 36 | QED Weighted: | 0.441 |
Caco-2 Permeability: | -4.863 | MDCK Permeability: | 0.00003500 |
Pgp-inhibitor: | 0.254 | Pgp-substrate: | 0.038 |
Human Intestinal Absorption (HIA): | 0.068 | 20% Bioavailability (F20%): | 0.01 |
30% Bioavailability (F30%): | 0.012 |
Blood-Brain-Barrier Penetration (BBB): | 0.688 | Plasma Protein Binding (PPB): | 95.97% |
Volume Distribution (VD): | 1.227 | Fu: | 4.97% |
CYP1A2-inhibitor: | 0.046 | CYP1A2-substrate: | 0.114 |
CYP2C19-inhibitor: | 0.569 | CYP2C19-substrate: | 0.376 |
CYP2C9-inhibitor: | 0.619 | CYP2C9-substrate: | 0.368 |
CYP2D6-inhibitor: | 0.094 | CYP2D6-substrate: | 0.308 |
CYP3A4-inhibitor: | 0.871 | CYP3A4-substrate: | 0.611 |
Clearance (CL): | 7.088 | Half-life (T1/2): | 0.009 |
hERG Blockers: | 0.008 | Human Hepatotoxicity (H-HT): | 0.217 |
Drug-inuced Liver Injury (DILI): | 0.458 | AMES Toxicity: | 0.034 |
Rat Oral Acute Toxicity: | 0.872 | Maximum Recommended Daily Dose: | 0.629 |
Skin Sensitization: | 0.02 | Carcinogencity: | 0.046 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.008 |
Respiratory Toxicity: | 0.961 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003300 | 0.752 | D06CWH | 0.253 | ||||
ENC004341 | 0.750 | D05VQI | 0.252 | ||||
ENC006059 | 0.750 | D0IN7I | 0.250 | ||||
ENC004468 | 0.737 | D0TB8C | 0.248 | ||||
ENC004026 | 0.709 | D09NNH | 0.247 | ||||
ENC006133 | 0.679 | D0V3ZA | 0.247 | ||||
ENC005175 | 0.650 | D0OB1J | 0.241 | ||||
ENC005506 | 0.650 | D0SP3D | 0.241 | ||||
ENC003763 | 0.650 | D01TSI | 0.240 | ||||
ENC003331 | 0.635 | D0UA0I | 0.240 |